Skip to main content

Xenon Pharmaceuticals Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics. We are advancing an ion channel product portfolio to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications.

Current Price

$54.12

-1.02%
Profile
Valuation (TTM)
Market Cap$4.50B
P/E-11.75
EV
P/B7.74
Shares Out83.19M
P/Sales
Revenue$0.00
EV/EBITDA

Xenon Pharmaceuticals Inc (XENE) Stock Chart

XENE

XENE Chart

Loading chart data…

XENE Interactive Stock Chart

Interactive stock chart for Xenon Pharmaceuticals Inc (XENE) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.

Current price: $54.12. 52-week high: $62.76. 52-week low: $28.49. 50-day moving average: $56.20. 200-day moving average: $44.96.

Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for XENE. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of Xenon Pharmaceuticals Inc's investment potential.